Purified Anti-Human CD279 Antibody[5C4.B8 (Nivolumab)] (AN006230P)
![Purified Anti-Human CD279 Antibody[5C4.B8 (Nivolumab)] - 1](http://file.elabscience.com/assets/images/loading.png)
Add to cart
For research use only.
| Verified Samples | Verified Samples in FCM: Human peripheral blood lymphocytes cell |
| Dilution | FCM 2 μg/mL(0.5×106-1×106 cells) |
| Isotype | Rabbit IgG, κ |
| Host | Rabbit |
| Reactivity | Human |
| Applications | FCM |
| Clonality | Monoclonal |
| Immunogen | Recombinant Human CD279 protein |
| Abbre | CD279 |
| Synonyms | SLEB, hSLE, Programmed Death, programmed cell death, Programmed cell death protein, Systemic lupus erythematosus susceptibility, hPD, PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1, programmed cell death 1, PD 1, CD279 antigen, hPD 1, hPD l, PDCD 1, Programmed cell death 1 protein, Programmed Death-1, Protein PD 1, Protein PD-1, Systemic lupus erythematosus susceptibility 2, Programmed cell death protein 1, CD279, CD279 antigen, hPD 1, hPD l, hPD-1, hSLE1, PD 1, PD-1, PD1, PDCD 1, PDCD1, PDCD1, Programmed cell death 1, Programmed cell death 1 protein, Programmed cell death protein 1, Protein PD 1, Protein PD-1, SLEB2, Systemic lupus erythematosus susceptibility 2 |
| Swissprot | |
| Concentration | ≥ 1 mg/mL |
| Buffer | Phosphate-buffered solution, pH 7.2, containing 0.05% non-protein stabilizer. Dialyze to completely remove the stabilizer prior to labeling. |
| Purification Method | >98%, Protein A/G purified |
| Research Areas | Cell Biology, Immunology, Cancer |
| Clone No. | 5C4.B8 (Nivolumab) |
| Conjugation | Unconjugated |
| Storage | Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. |
| Shipping | Ice bag |
| background | rogrammed Death-1 (PD-1) is a type I transmembrane protein belonging to the CD28/CTLA-4 family of immunoreceptors that mediate signals for regulating immune responses . Members of the CD28/CTLA-4 family have been shown to either promote T cell activation (CD28 and ICOS) or down-regulate T cell activation (CTLA-4 and PD-1). |
| Cat.No. | Product Name | Clone No. |
|---|
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.sample_type}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
